Ovarian Cancer
📧 Sign up to get email alerts when something new happens for Ovarian Cancer.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS research · 2026-01-26Clinical Trial Update: Biomarkers of Resiliency In Childhood Cancer Surgery
Clinical trial update from Mayo Clinic on biomarkers of resiliency in pediatric cancer surgery, currently recruiting.
-
EMA approval · 2026-01-23EMA Authorised: Elahere (mirvetuximab soravtansine) — AbbVie Deutschland GmbH & Co. KG
The European Medicines Agency authorised Elahere (mirvetuximab soravtansine) for ovarian cancer, fallopian tube cancer and peritoneal cancer…
-
CLINICAL_TRIALS research · 2026-01-23Clinical Trial Update: Exploring the Effects of Hand and Foot Exercise Intervention in Older Adults With Gynecological Cancer Receiving Chemotherapy Improvement of Peripheral Neuropathy and Quality of Life [NA]
A trial is exploring whether a hand and foot exercise program can reduce chemotherapy-induced peripheral neuropathy and improve quality of l…
-
CLINICAL_TRIALS research · 2026-01-23Clinical Trial Update: A Study of Opportunistic Salpingectomy to Prevent Ovarian Cancer [NA]
A clinical trial is evaluating opportunistic salpingectomy as a preventive measure to reduce ovarian cancer risk, and it is currently recrui…
-
CLINICAL_TRIALS trial_result · 2026-01-23Clinical Trial Update: Exploration of DNA Methylation as a Marker for Early Detection of High Grade Serous Epithelial Ovarian Cancer
A Baylor Research Institute-led clinical trial evaluating DNA methylation as an early-detection marker for high-grade serous ovarian cancer …
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS trial_result · 2026-01-23Clinical Trial Update: SLV-154 Treatment of Metastatic Solid Tumors [Phase 1]
Phase 1 clinical trial update for SLV-154 evaluating treatment of metastatic solid tumors. The study is currently recruiting across multiple…
-
CLINICAL_TRIALS trial_result · 2026-01-22Clinical Trial Update: A Phase 1 in Patients With HLA-A*0201+ and WT1+ Recurrent/Metastatic Cancers [Phase 1]
Phase 1 trial evaluating a WT1-targeted immunotherapy in HLA-A*0201+ WT1+ recurrent/metastatic cancers has completed, including colorectal c…
-
CLINICAL_TRIALS research · 2026-01-22Clinical Trial Update: Phase 1b of Lurbinectedin in Combination With Weekly Paclitaxel and Bevacizumab in Platinum-resistant Ovarian Cancer [Phase 1]
A Phase 1b trial is evaluating lurbinectedin in combination with weekly paclitaxel and bevacizumab for platinum-resistant ovarian cancer; th…
-
CLINICAL_TRIALS trial_result · 2026-01-21Clinical Trial Update: Sacituzumab Govitecan for Relapsed Ovarian, Endometrial, and Cervical Carcinomas [Phase 2]
Phase 2 trial of sacituzumab govitecan for recurrent platinum-resistant epithelial ovarian cancer, recurrent epithelial endometrial cancer, …
-
CLINICAL_TRIALS research · 2026-01-21Clinical Trial Update: A Randomized, Open-label, Double-cohort Study of Fluzoparib Combined With Famitinib Malate or SHR-1701 for Neoadjuvant Therapy in Patients With Advanced Ovarian Cancer [Phase 2]
Phase 2 randomized neoadjuvant trial evaluating Fluzoparib in combination with Famitinib Malate or SHR-1701 for advanced ovarian cancer; the…
-
CLINICAL_TRIALS research · 2026-01-21Clinical Trial Update: EXoPERT EMERALD Clinical Study
Clinical trial update indicates the EXoPERT EMERALD study is currently recruiting across multiple cancer indications, including breast, colo…
-
CLINICAL_TRIALS other · 2026-01-21Clinical Trial Update: Clinical Study of EZH2 Inhibitor Combined With PARP Inhibitor in the Treatment of Patients With Advanced or Recurrent Epithelial Ovarian Cancer. [Phase 2]
Phase 2 clinical study evaluating the combination of an EZH2 inhibitor with a PARP inhibitor for advanced or platinum-sensitive recurrent ep…
-
EMA approval · 2026-01-20EMA Authorised: Hycamtin (topotecan) — Sandoz Pharmaceuticals d.d.
EMA authorised Hycamtin (topotecan) by Sandoz Pharmaceuticals d.d. for the treatment of ovarian cancer, cervical cancer, and small cell lung…
-
CLINICAL_TRIALS research · 2026-01-20Clinical Trial Update: A Study to Assess Adverse Events, Change in Disease Activity and How Intravenous (IV) ABBV901 Moves Through the Body Alone or in Combination With Bevacizumab in Adult Participants With Ovarian Cancer [Phase 1]
Phase 1 study to assess adverse events, changes in disease activity, and pharmacokinetics of intravenous ABBV901 given alone or with Bevaciz…
-
CLINICAL_TRIALS research · 2026-01-16Clinical Trial Update: AZD5335 vs. Mirvetuximab Soravtansine in FRα-high and AZD5335 vs. Chemotherapy in FRα-low Platinum-resistant Ovarian Cancer [Phase 3]
Phase 3 trial recruitment is ongoing for AZD5335 versus Mirvetuximab Soravtansine in FRα-high epithelial ovarian cancer and AZD5335 versus c…
-
CLINICAL_TRIALS research · 2026-01-16Clinical Trial Update: Juice Plus+ and Juice Plus+ Complete in Ovarian Cancer [Phase 2]
Phase 2 clinical trial evaluating Juice Plus+ and Juice Plus+ Complete in ovarian cancer is currently active but not recruiting.
-
CLINICAL_TRIALS research · 2026-01-16Clinical Trial Update: Lead-212 PSV359 Therapy for Patients With Solid Tumors [Phase 1, Phase 2]
Perspective Therapeutics reports that Lead-212 PSV359 Therapy is being studied in Phase 1/2 trials for multiple solid tumors and is currentl…
-
CLINICAL_TRIALS research · 2026-01-16Clinical Trial Update: Study to Assess Safety, Tolerability and Activity of DSB2455 in Participants With Advanced Malignancies [Phase 1]
Phase 1 study update for DSB2455 assessing safety, tolerability, and activity in advanced HRD-associated cancers, including breast cancer, o…
-
CLINICAL_TRIALS research · 2026-01-15Clinical Trial Update: Sample Collection for Ongoing Research and Product Evaluation Study
Natera reports an ongoing study update focused on sample collection for ongoing research and product evaluation; the trial is currently recr…
-
CLINICAL_TRIALS research · 2026-01-15Clinical Trial Update: A Study of DM002 in Patients With Advanced Solid Tumors [Phase 1]
Phase 1 clinical trial for DM002 in patients with advanced solid tumors is recruiting, including ovarian cancer, prostate cancer, endometria…
-
CLINICAL_TRIALS research · 2026-01-14Clinical Trial Update: Phase I Study of Tumor Treating Fields (TTF) in Combination With Cabozantinib or With Pembrolizumab and Nab-Paclitaxel in Patients With Advanced Solid Tumors Involving the Abdomen or Thorax [Phase 1]
Phase I trial updates the use of Tumor Treating Fields in combination with cabozantinib or with pembrolizumab and nab-paclitaxel for various…
-
CLINICAL_TRIALS research · 2026-01-14Clinical Trial Update: Safety and Efficacy Study of NUV-1511 in Adult Patients With Advanced Solid Tumors [Phase 1, Phase 2]
Clinical trial update on the Phase 1/Phase 2 safety and efficacy study of NUV-1511 in adults with advanced solid tumors, including HER2-nega…
-
CLINICAL_TRIALS research · 2026-01-14Clinical Trial Update: A Study of CUSP06 in Patients With Platinum-Refractory/Resistant Ovarian Cancer and Other Advanced Solid Tumors [Phase 1]
A Phase 1 clinical trial evaluating CUSP06 in patients with platinum-refractory/resistant ovarian cancer and other advanced solid tumors is …
-
CLINICAL_TRIALS research · 2026-01-14Clinical Trial Update: A Study of LY4170156 in Participants With Selected Advanced Solid Tumors [Phase 1]
An early-phase study evaluating LY4170156 in selected advanced solid tumors is currently recruiting.
-
CLINICAL_TRIALS trial_result · 2026-01-14Clinical Trial Update: ASA in Prevention of Ovarian Cancer (STICs and STONEs) [Phase 2]
Phase 2 trial evaluating aspirin (acetylsalicylic acid) for prevention of ovarian cancer; status is active but not recruiting.